Sudan Black B

Networked: 37 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results


1. Ossenkoppele, Gert J: 1 article (03/2013)
2. van Beckhoven, Ernest: 1 article (03/2013)
3. van der Veeken, Yvonne F C M: 1 article (03/2013)
4. van de Loosdrecht, Arjan A: 1 article (03/2013)
5. Loonen, Anne: 1 article (03/2013)
6. van den Ancker, Willemijn: 1 article (03/2013)
7. Westers, Theresia M: 1 article (03/2013)
8. de Leeuw, David C: 1 article (03/2013)
9. Choi, Hyun-Woo: 1 article (10/2008)
10. Kim, Hye-Ran: 1 article (10/2008)

Related Diseases

1. Leukemia
03/01/2013 - "In this study, we investigated whether or not a cut-off of 10% positivity for cMPO equally defines an acute leukemia as AML or MPAL as compared to a cut-off for cMPO of 20% and compared this with results obtained for Sudan Black B (SBB) staining by cytomorphology. "
08/01/1990 - "Conversely, occasional cases of Sudan black B-positive ALL can be confused with myeloblastic leukemia. "
06/01/2001 - "We propose following modified criteria for AML-M0: (1) standard criteria for acute leukemia; (2) undetectable or less than 3% MPO or Sudan black B staining in blasts; (3) lack of expression of lymphoid-specific antigens, cyCD3 for T lineage and cyCD79 and cyCD22 for B lineage; and (4) positivity for any of the myelomonocytic lineage antigens known not to be expressed on normal T or B lymphocytes or positivity for MPO as detected by ultrastructural cytochemistry, immunohistochemistry, or flow cytometry."
02/01/1993 - "In a series of 63 patients with newly diagnosed acute leukemia who were admitted to the Main Hospital of Nippon Medical School, five patients fit the criteria for AML-M0: negative myeloperoxidase (MPO) and Sudan black B reaction by light microscopy, negative for B- and T-lineage markers, and positive for myeloid markers. "
11/15/1991 - "The authors therefore suggest that immunophenotyping, when combined with cytochemical analysis of TdT and myeloperoxidase or Sudan black B, may aid in the characterization of subgroups of atypical acute leukemia, such that alternate approaches to therapy can be evaluated."
2. Acute Promyelocytic Leukemia
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
5. Atherosclerosis

Related Drugs and Biologics

1. Peroxidase (Myeloperoxidase)
2. Esterases
3. Periodic Acid
4. Carboxylesterase (Hydrolase S)
5. Tolonium Chloride
6. Paraffin
7. Lipids
8. Antigens
9. Acid Phosphatase
10. naphthylbutyrate esterase

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)